Brittany Fitzgerald

Associate Director at Orange Grove Bio
  • Claim this Profile
Online Presence
Contact Information

Topline Score

Bio

Generated by
Topline AI

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.

0

/5.0
/ Based on 0 ratings
  • (0)
  • (0)
  • (0)
  • (0)
  • (0)

Filter reviews by:

No reviews to display There are currently no reviews available.
You need to have a working account to view this content. Click here to join now

Experience

    • United States
    • Biotechnology Research
    • Associate Director
      • Aug 2021 - 2 years 5 months

      Orange Grove Bio (“OGB”) is a preclinical drug development platform focused on driving down the cost of drug discovery and advancing therapies into clinical trials. ​ We are partnered with leading universities to license transformational medicines. OGB and its university partners streamline the licensing process to speed up the development process to get drugs to market faster and to save time on-patent. ​ Orange Grove also sources programs through investment in preclinical stage… Show more Orange Grove Bio (“OGB”) is a preclinical drug development platform focused on driving down the cost of drug discovery and advancing therapies into clinical trials. ​ We are partnered with leading universities to license transformational medicines. OGB and its university partners streamline the licensing process to speed up the development process to get drugs to market faster and to save time on-patent. ​ Orange Grove also sources programs through investment in preclinical stage biotech companies. OGB’s experienced development team works with these companies to more efficiently advance programs into the clinic and hit additional value-inflection points. ​ Regardless of the approach, our mission is to work to bring forward more treatments to treat patients and cure disease. https://www.orangegrovebio.com/ Show less

Community

You need to have a working account to view this content. Click here to join now